Epatopatia e infezione da virus dell'epatite B nei pazienti in dialisi: studio trasversale.

Translated title of the contribution: Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study

F. Fabrizi, S. Bisegna, S. Mangano, G. Alongi, P. Colucci, S. Finazzi, A. F. De Vecchi, C. Ponticelli

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Control of spread of HBV infection in dialysis units in developed countries has been one of the major advances in managing end-stage renal disease (ESRD). Patients with chronic HBV, however, continue to enter the population pool of dialysis patients and transplant candidates. The clinical significance related to the presence of HBsAg in serum of dialysis patients has not been completely understood. AIM AND METHODS: We collected demographic, biochemical and virological data from a large (n=464) population of patients on maintenance dialysis. This was done to assess the influence of virological and host factors on hepatocellular damage, as shown by serum aminotransferase activity. RESULTS: The frequency of HBsAg positivity in our dialysis population was 8.2 % (38/464); the rate of HBsAg positive patients showing HBe antigen was 20.6% (7/34). Twenty-two (84.6%) of 26 HBsAg positive patients showed detectable HBV DNA in serum by Amplicor HBV MonitorTM Test. HBsAg positive patients had serum aminotransferase activity significantly higher than HBsAg negative individuals; GOT (AST) 25.1+/-29.9 vs. 16+/-21.5 UI/L (p=0.001), and GPT (ALT) 31.3+/-52.5 vs. 17.7+/-21.9 UIL (p=0.034). In the subset of HBsAg positive dialysis patients, those in the replicative phase HBeAg positive) had aminotransferase activity higher than HBeAg negative individuals, AST, 42.3+/-43.6 vs. 22.4+/-27.3 UI/L (p=0.097) and ALT, 49.41+/-54.7 vs. 29.17+/-55.76 UI/L (NS) respectively. We did a multivariate analysis by standard least square model on the entire patient group and we found independent and significant association between detectable HBsAg in serum and AST (p=0.0089)and ALT (p=0.0159) values. There was an independent and significant relationship between age and ALT (p=0.01). CONCLUSIONS: In our study group, HBsAg positive patients on dialysis had serum aminotransferase activity significantly higher than that measured in HBsAg negative individuals. However, mean transaminase levels in HBsAg positive patients on dialysis were below the upper limit of normal for the reference range of healthy controls. HBsAg positive dialysis patients with active viral replication showed the greatest liver damage. Studies are in progress to understand further HBV-related liver disease in dialysis population.

Translated title of the contributionHepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study
Original languageItalian
Pages (from-to)149-154
Number of pages6
JournalGiornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Volume19
Issue number2
Publication statusPublished - Mar 2002

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study'. Together they form a unique fingerprint.

  • Cite this

    Fabrizi, F., Bisegna, S., Mangano, S., Alongi, G., Colucci, P., Finazzi, S., De Vecchi, A. F., & Ponticelli, C. (2002). Epatopatia e infezione da virus dell'epatite B nei pazienti in dialisi: studio trasversale. Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia, 19(2), 149-154.